Meet-the-Expert 1 – Hematologic malignancy / HSCT

• Guillermo J. Ruiz-Argüelles  (Past-President, ISH | Center of Hematology and Internal Medicine of Puebla, Mexico) 
• David Gómez-Almaguer (Past-President, ISH | UANL, Mexico)
• Pimjai Niparuck (Ramathibodi Hospital, Mahidol University, Thailand)
• Kannadit Prayongratana (Phramongkutklao Hospital, Thailand)

Coffee break | Exhibition | Poster viewing

Symposium 11 - Chronic Myeloid Leukemia

Chairs: Saengsuree Jootar
            Chittima Sirijerachai

• Current treatment strategies and guidance for CML as of 2026
  Jane Apperley (Imperial College, UK)  
• Advanced treatment with asciminib for CML
  David Yeung (Adelaide University, Australia)  
• Real world data and clinical experience with asciminib in CML       
  Pimjai Niparuck (Ramathibodi Hospital, Mahidol University Thailand)

Lunch Symposium V Novartis

“STAMPing the Future of CML: From Myristoyl Pocket Science to Clinical Insight”

     Moderator: Saengsuree Jootar (Ramathibodi Hospital, Thailand)
     Speaker: David Yeung (Royal Adelaide Hospital, Australia)

Lunch Symposium VI AstraZeneca

"From Transfusion Dependence to Disease Control: Redefining PNH Management in Clinical Practice"

Moderator: Bundarika Suwanawiboon (Siriraj Hospital, Thailand)
Speaker: Danny Hsu (Liverpool Hospital, Australia)

Oral Presentation I
Benign/Transfusion Medicine

Chairs: Nonglak Kanitsup  
            Peerapon Wong

• OP-I-01 Inflammatory cytokines, thrombocytopenia, and hyperferritinemia in dengue infection: Hematological and biochemical correlates from a tertiary care study
  Arun Kumar Singh, Brij Raj Jaiswal 
   
• OP-I-02 Impact of anticoagulant duration on survival outcomes in cancer associated thrombosis: Evidence from a Thai population 
  Lantarima Bhoopat, Naritsara Wongthong, Pattarin Pirompanich, Nathaorn Phuangsombut, Darunee Emrat, Kodchanut Litleaungdej, Peewara Chormanee, Baibun Sripimolwan, Pacharaporn Dedpirattanamongkhon, Hataiwan Ratanabunjerdkul, Nonglak Kanitsap
   
• OP-I-03 Ineffective erythropoiesis, not iron overload, drives pro- inflammatory activation in -thalassemia: Insights from cytokine profiling across clinical phenotypes
  Lalit Prashant Meena, Siddhartha Shankar Das
   
• OP-1-04 A two-year follow-up on the efficacy and safety of low-dose hydroxyurea and thalidomide in beta-thalassemia patients at Ramathibodi Hospital 
  Phatsorn Choksomnuk, Suporn Chuncharunee, Pimjai Niparuck, Pichika Chantrathammachart, Kochawan Boonyawat, Teeraya Puavilai, Siriwan Anantato
   
• OP-I-05 Endothelial micropartice dynamics predict survival in trauma: A prospective study assessing temporal trends in cytokines and microparticles 
  Rupali Awale, Amit Kumar, Mohit Mohit, Vikas Aggarwal, Mallikarjun Gunjiganvi 
   
• OP-I-06 Development of an electronic platform to enhance hemophilia care at a hemophilia treatment center 
  Pitirat Puksee, Nongnuch Sirachainan, Pattara Karnjanakan, Hathamol Chanwarangkul, Apiwat Akarapattananukul, Ketsuda Kempka, Sanikarn Nakrong, Ampaiwan Chuansumrit 
   
• OP-I-07 Effectiveness of romiplostim and eltrombopag as dual agent in treatment of aplastic anemia: A prospective study 
  Subhra Kamal Saha, Tuphan Kanti Dolai, Subham Bhattacharya, Suprotim Ghosh 
   
• OP-I-08 Response of thalidomide in transfusion dependent thalassemia 
  Md. Ashikuzzaman

Coffee break | Exhibition | Poster viewing

Symposium 13 - Bone Marrow Failure

Chairs: Nongnuch Sirachainana
            Archrob Khuhapinant 

•  Bone marrow failure in children 
  Hideki Muramatsu (Nagoya University Graduate School of Medicine, Japan) 
• Myelodysplasia/leukemia in inherited bone marrow failure syndromes, data from the Canadian inherited bone marrow failure registry           
  Yigal Dror (SickKids, Canada)  
• Aplastic anemia in dults: From initial diagnosis to therapeutic strategy
  Chattree Hantaweepant (Siriraj Hospital, Mahidol University, Thailand) 

Dinner Symposium III – Thai Meiji

Rezurock: A New Innovative Treatment for cGVHD – From Evidence to Clinical Practice

Moderator: Adisak Tantiworawit (Chiangmai University, Thailand)
Speakers: Kitsada Wudhikarn (Chulalongkorn University, Thailand)
                 Pimjai Niparuck (Ramathibodi Hospital, Mahidol University, Thailand)

Meet-the-Expert 2 - Red cell disorder

• Ali Amid (University of British Columbia, Canada)  
• Bunchoo Pongtanakul (Siriraj Hospital, Mahidol University, Thailand)
• Nattiya Teawtrakul (Khon Kaen University, Thailand)

Coffee break | Exhibition | Poster viewing

Symposium 12 - Bleeding Disorders

Chairs:  Ponlapat Rojnuckaring
             Darintr Sosothikul

• Unmet needs for hemophilia treatment               
  Pantep Angchaisuksiri (Ramathibodi Hospital, Mahidol University, Thailand) 
• Thrombotic microangiopathy
  Danny Hsu (Liverpool Hospital, Australia)              
• Update on the management of immune thrombocytopenia in pregnancy 
  Bundarika Suwanawiboon (Siriraj Hospital, Mahidol University, Thailand)

Oral Presentation II
Malignancy/HSCT

Chairs: Ekapun Karoopongse 
            Piya Rujkijyanont

• OP-II-01 Implication of AHR signaling in therapeutic response of acute myeloid leukemia
  Patit Choksawangkarn, Tamilla Nechiporuk, Daniel Bottomly, Jeffrey Tyner, Suradej Hongeng, Patompon Wongtrakoongate, Alisa Damnernsawad
   
• OP-II-02 Prospective evaluation of FxCycle Violet based flow cytometric DNA ploidy analysis in newly diagnosed B-acute lymphoblastic leukemia
  Smeeta Gajendra, Ritu Gupta, Sanjeev Kumar Gupta, Sandeep Rai, Saroj Singh, Sameer Bakhshi, Rachna Seth
   
• OP-II-03 Key factors in managing B-cell non-Hodgkins lymphoma in limited-and well-resourced hospitals in Southeast Asia 
  Lalita Norasetthada, Priscilla Caguioa, Kitsada Wudhikarn, Gin Gin Gan, Huynh Van Man, Damai Santosa, Junice Ng, Puja Khanna, Neeyor Bose, Amanda Woo, Yi Qi Ng, Michelle Poon
   
• OP-II-04 Statin exposure and survival in multiple myeloma: A systemic review and meta-analysis of population-based cohorts
  Caryn Louise Gutierrez, April Joy Ong, Teresita Dumagay
   
• OP-II-05 Optimization of pre-apheresis blood CD34 value for guiding plerixafor administration as rescue therapy to succeed in peripheral blood stem cell mobilization for lymphoma patients with poor mobilizers
  Supanut Kumjan, Phenphicha Kaewphichai, Kitsada Wudhikarn, Ponlapat Rojnuckarin, Chantiya Chanswangphuwana
   
• OP-II-06 Impact of EWALL-PI index and cytogenetic risk stratification on clinical outcomes in acute lymphoblastic leukemia
  Hina Tahir
   
• OP-II-07 Mathematical modeling of a longitudinal bone-marrow Niche digital twin quantifies therapy-induced leukemic stem-cell persistence and relapse escape in acute myeloid leukemia
  Rifaldy Fajar, Prihantini Prihantini, Rini Winarti, Riana Dwi Kurniawati
   
• OP-II-08 Early immature platelet count kinetics predict platelet engraftment after hematopoietic stem cell transplantation
  Wan-jou Lin, Tsung-han Yang, Chun-kuang Tsai, Hao-yuan Wang, Po-shen Ko, Sheng-hsuan Chien, Ting-an Lin, Chiu-mei Yeh, Ching-i Lu, Te-lin Hsu, Chia-jen Liu

Coffee break | Exhibition | Poster viewing

Symposium 14 - Precision in hematology

Chairs: Supanun Lauhasurayotin 
            Thanawat Rattanathammethee

• Role of next generation sequencing in lymphoma    
  Zhiliang Chen (SOPHiA Genetics, Switzerland)  
• Precision matters: Redefining hematology pharmacotherapy with pharmacogenomics       
  Pajaree Chariyavilaskul (Chulalongkorn University, Thailand) 

Meet-the-Expert 3 - Bleeding-thrombosis

• Danny Hsu (Liverpool Hospital, Australia)  
• Noppachan Uaprasert (Chulalongkorn University, Thailand) 
• Pichika Chantrathammachart (Ramathibodi Hospital, Mahidol University Thailand)

Coffee break | Exhibition | Poster viewing

Education Session: Hematology Training

Chairs: Kitti Torcharus 
            Theera Ruchutrakool 

• Hematology Education and Training in Digital Era
  Sabri Kemahli (Alfaisal University, College of Medicine Riyadh, S. Arabia)  

Oral Presentation III
Pediatric Hematology/Oncology

Chairs: Samart Pakakasama 
            Patcharapan Suraponchai

• OP-III-01 Elevated expression TP53 isoforms delta133p53 and delta40p53 are associated with lower probability of relapse in pediatric B cell acute lymphoblastic leukemia
  Minu Singh, Parminder Kaur, Hasib TK, Sargeet Kaur, Prateek Bhatia, Amita Trehan, Manupdesh Singh Sachdeva, Sreejesh Sreedharanunni
   
• OP-III-02 Assessing doctors’ attitudes on palliative treatment (ADAPT) survey to evaluate provider perspectives regarding pediatric palliative care in Thailand and Asia-Pacific
  Pornpun Sripornsawan, Chusana Khaiman, Lalita Sathitsamitphong, Patcharee Komvilaisak, Nassawee Vattana, Sommaphun Tabjaroen, Marta Salek, Andrea Cuviello, ADAPT-AP study team
   
• OP-III-03 Bridging survival to survivorship in Thailand: A multicenter study of healthcare providers' perceptions
  Praeploy Amornsillaphachai, Nawachai Lertvivatpong, Kannapob Sirichotiwat, Ploypun Narindrarangkura, Phakatip Sinlapamongkolkul, Samart Pakakasama, Daranee Isaranimitkul, Piti Techavichit, Sureeporn Chingnawan, Pariwan Sripattanatadasakul, Lalita Sathitsamitphong, Angkana Winaichatsak, Chayamon Takpradit, Khemika Sudnawa, Kunanya Suwannaying, Chalinee Monsereenusorn
   
• OP-III-04 Bioinformatics reconstruction of MIRNA-driven mesenchymal stromal niche failure indicates incomplete microenvironmental recovery after transplantation in Fanconi anemia
  Rini Winarti, Rifaldy Fajar, Prihantini Prihantini, Sahnaz Vivinda Putri
   
• OP-III-05 Predicted 10-year survival in acute myeloid leukemia (AML): Single-center experience at the department of clinical haematology, North Okkalapa General Hospital
  Yi Thant, Hnin Mya Thanda Thanda, Mie Mie Khaing Khaing, Yin Nwet Han Han, Khin Thida Htut Htut, Sein Win Win, Aye Aye Gyi
   
• OP-III-06 Real-world effectiveness and safety of CPX-351 as first-line therapy for acute myeloid leukemia in a single center
  Oh Kwan Ee, Akashi Naoki, Iino Hiromasa, Hoshino Takumi, Hatsumi Nahoko, Takada Satoru
   
• OP-III-07 Efficacy of ARA-C and GCSF for hematopoietic stem cell mobilization compared to other regimen in autologous stem cell transplantation patients in bone marrow transplantation unit of non-medical school center in Thailand
  Penpun Piwbuakum, Naiyana Mahapo, Thanakrit Somprasertkul, Komsai Suwanno, and Anoree Surawong

Coffee break | Exhibition | Poster viewing

Oral Presentation 4
(Thai Hematology Trainees Research Competition)

Chairs: Chanchai Trivaree
             Yingyong Chinthammitr

• OP-IV-01 Predictors of moderate-to-severe acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in severe thalassemia
  Anusak Sakwit, Usanarat Anurathapan
   
• OP-IV-02 Outcome of busulfan therapeutic drug monitoring in Thai pediatric patients undergoing hematopoietic stem cell transplantation: A single-center study
  Cholkanok Cholpattana, Cholada Ratanatharathorn, Bunchoo Pongtanakul, Chayamon Takpradit, Kleebsabai Sanpakit, Nattee Narkbunnam
   
• OP-IV-03 Long-term efficacy of once daily versus twice daily aspirin in high-risk myeloproliferative neoplasms patients with aspirin resistance
  Kanyapak Leeisaranukul, Yingyong Chinthammitr, Theera Ruchutrakool, Archrob Khuhapinant, Bundarika Suwanawiboon, Ekapun Karoopongse, Weerapat Owattanapanich, Ployplern Phikulsod, Chutima Kunacheewa,Chattree Hantaweepant, Smith Kungwankiattichai, Tarinee Rungjirajittranon, Pongthep Vittayawacharin, Jane Jianthanakanon, Nawapotch Donsakul, Sitanun Preechathaveekid, Yupa Nakklinkul, Kanthika Lumpoon, Thanaporn Jaturonvanich
   
• OP-IV-04 Change in plasma thrombin generation potential and thrombomodulin resistance in beta-thalassemia/hemoglobin E
  Kavin Fongsataporn, Pichika Chantrathammachart, Pantep Angchaisuksiri, Nigel Key, Yuriy Prokopenko, Pimjai Niparuck, Teeraya Puavilai, Kochawan Boonyawat, Thanakrit Piyajaroenkij 
   
• OP-IV-05 Impact of vitamin D deficiency on quality of life and clinical outcomes in patients with multiple myeloma
  Kawita Kitichotkul, Teerachat Punnachet, Piangrawee Niprapan, Nonthakorn Hantrakun, Sasinee Hantrakool, Thanawat Rattanathammethee, Chatree Chai-Adisaksopha, Ekarat Rattarittamrong, Adisak Tantiworawit, Lalita Norasetthada, Pokpong Piriyakhuntorn, Sirichai Srichairatanakool
   
• OP-IV-06 Predictive performance of venous thromboembolism risk assessment models in critically ill Thai patients in a medical ICU: A prospective cohort study
  Peampost Sinsakolwat, Piangrawee Niprapan, Lalita Norasetthada, Adisak Tantiworawit, Ekarat Rattarittamrong, Thanawat Rattanathammethee, Sasinee Hantrakool, Pokpong Piriyakhuntorn, Nonthakorn Hantrakun, Teerachat Punnachet, Sirichai Srichairatanakool, Chatree Chai-Adisaksopha
   
• OP-IV-07 Correlation between chromameter-assessed skin lightness and MRI-derived liver iron concentration in thalassemia patients
  Phimprapha Khumngeon, Sasinee Hantrakool, Napatra Tovanabutra, Thanat Kanthawang, Piangrawee Niprapan, Sirichai Srichairatanakool,
  Teerachat Punnachet, Nonthakorn Hantrakun, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Chatree Chai-Adisaksopha, Ekarat Rattarittamrong, Adisak Tantiworawit., Lalita Norasetthada
   
• OP-IV-08 Generation, expansion and functional characterization of natural killer cells derived from mobilized hematopoietic stem cells for cancer immunotherapy
  Suppanut Komjakraphan, Poonnattha Anantasaeree, Kajornkiat Maneechai, Watsamon Uraiwan, Jakrawadee Julamanee, Panarat Noiperm
   
• OP-IV-09 Adjunct resveratrol or omeprazole in non-transfusion dependent thalassemia patients with secondary hemochromatosis: A randomized, double-blind, placebo-controlled trial
  Thanapong Chopetgool, Adisak Tantiworawit, Chatree Chai-adisaksopha, Ekarat Rattarittamrong, Lalita Norasetthada, Thanawat Rattanathammethee, Sasinee Hantrakool, Pokpong Piriyakhuntorn, Teerachat Punnachat, Nonthakorn Hantrakun, Sirichai Srichairatanakool, Pimpisid Koonyosying, Somdet Srichairatanakool